Catalent Inc (CTLT)

[APDN 4 LIFE]

IPO for Catalent opens at $20/share, Priced at $20.50

[APDN 4 LIFE]

Catalent, Inc. Overview - $CTLT

We are the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Our oral, injectable, and respiratory delivery technologies address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. Through our extensive capabilities and deep expertise in product development, we help our customers take products to market faster, including nearly half of new drug products approved by the FDA in the last decade.

Our advanced delivery technology platforms, broad and deep intellectual property, and proven formulation, manufacturing and regulatory expertise enable our customers to develop more products and better treatments. Across both development and delivery, our commitment to reliably supply our customers’ needs is the foundation for the value we provide; annually, we produce more than 70 billion doses for nearly 7,000 customer products. We believe that through our investments in growth-enabling capacity and capabilities, our ongoing focus on operational and quality excellence, the sales of existing customer products, the introduction of new customer products, our patents and innovation activities, and our entry into new markets, we will continue to benefit from attractive and differentiated margins, and realize the growth potential from these areas.

http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001193125-14-077809%2Etxt&FilePath=%5C2014%5C02%5C28%5C&CoName=CATALENT%2C+INC%2E&FormType=S-1%2FA&RcvdDate=2%2F28%2F2014&pdf=

[Unclear]

Catalent a provider of oral, injectable and respiratory drug delivery technologies. Catalent plans to raise $871 million by offering 42.5 million shares at 19 to 22 a share.

http://www.nasdaq.com/markets/ipos/company/catalent-inc-925423-74481